The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Molecular cloning, expression and characterization of the human serine/threonine kinase Akt‐3
Open accessAbstract
Akt (also known as PKB or RAC‐PK) is an intracellular serine/threonine kinase involved in regulating cell survival. Although this makes it a promising target for the discovery of drugs to treat human cancer, a complicating factor may be the role played by Akt in insulin signalling. Two human isoforms, Akt‐1 and Akt‐2, have been described previously and a third isoform has been identified in rats (here termed Akt‐3, but also called RAC‐PK‐γ or PKB‐γ). We describe the identification of the corresponding human isoform of Akt‐3. The gene encoding human Akt‐3 was localized to chromosome 1q43–44. The predicted protein sequence is 83% identical to human Akt‐1 and 78% identical to human Akt‐2, and contains a pleckstrin homology domain and a kinase domain. In contrast to the published rat Akt‐3 isoform, human and mouse Akt‐3 also possess a C‐terminal ‘tail’ that contains a phosphorylation site (Ser472) thought to be involved in the activation of Akt kinases. In addition to phosphorylation of Ser472, phosphorylation of Thr305 also appears to contribute to the activation of Akt‐3 because mutation of both these residues to aspartate increased the catalytic activity of Akt‐3, whereas mutation to alanine inhibited activation. Akt‐3 activity could be inhibited by the broad spectrum kinase inhibitor staurosporine and by the PKC inhibitor Ro 31‐8220, but not by other PKC or PKA inhibitors tested. Although Akt‐3 is expressed widely, it is not highly expressed in liver or skeletal muscle, suggesting that its principle function may not be in regulating insulin signalling. These observations suggest that Akt‐3 is a promising target for the discovery of novel chemotherapeutic agents which do not interfere with insulin signalling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogenic Activation, Phosphorylation, and Nuclear Translocation of Protein Kinase Bβ
Meier, R., Alessi, D. R., Cron, P., Andjelković, M., & Hemmings, B. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.48.30491 · Cited by 378
Cited by
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Tschopp, O., Yang, Z.-Z., Brodbeck, D., Dummler, B. A., Hemmings-Mieszczak, M., Watanabe, T., Michaelis, T., Frahm, J., & Hemmings, B. A. (2005) · Development · doi:10.1242/dev.01864 · Cited by 413
The survival kinases Akt and Pim as potential pharmacological targets
Amaravadi, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26273 · Cited by 408
BARNETT, S. F., DEFEO-JONES, D., FU, S., HANCOCK, P. J., HASKELL, K. M., JONES, R. E., KAHANA, J. A., KRAL, A. M., LEANDER, K., LEE, L. L., et al. (2005) · Biochemical Journal · doi:10.1042/bj20041140 · Cited by 396
Dai, D. L., Martinka, M., & Li, G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.168 · Cited by 318
Metadata
- Authors
- Masure, S., Haefner, B., Wesselink, J., Hoefnagel, E., Mortier, E., Verhasselt, P., Tuytelaars, A., Gordon, R., & Richardson, A.
- Venue
- European Journal of Biochemistry
- Publisher
- Wiley
- Published
- 1999-10
- Volume
- 265
- Issue
- 1
- Pages
- 353-360
- ISSN
- 0014-2956 (ISSN-L)
- 1432-1033
- OpenAlex
- W2018786910
- Cited by
- 159
- References
- 1
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular cloning, expression and characterization of the human serine/threonine kinase Akt‐3. https://app.cochat.ai/papers/10.1046/j.1432-1327.1999.00774.x
- The paper
- Masure, S., Haefner, B., Wesselink, J., Hoefnagel, E., Mortier, E., Verhasselt, P., Tuytelaars, A., Gordon, R., & Richardson, A. (1999). Molecular cloning, expression and characterization of the human serine/threonine kinase Akt‐3. European Journal of Biochemistry. https://doi.org/10.1046/j.1432-1327.1999.00774.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.